Divis Laboratories Ltd | DIVI - Debt

Stock Price
6,470.00
Daily Change
108.50 1.71%
Monthly
8.79%
Yearly
7.36%
Q2 Forecast
6,221.55

Divis Laboratories Ltd reported INR40M in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Aurobindo Pharma INR 82.63B 1.64B Mar/2025
Avita Medical AUD 46.05M 1.46M Dec/2025
Dianthus Therapeutics USD 1.28M 45K Sep/2025
Divis Laboratories Ltd INR 40M 40M Mar/2025
Ionis Pharmaceuticals USD 2.33B 1.1B Dec/2025
IQVIA Holdings USD 15.72B 767M Dec/2025
Lupin INR 54.48B 20.05B Mar/2025
Moderna USD 734M 7M Sep/2025
Organon & Co USD 8.83B 68M Sep/2025
Revvity USD 3.37B 5.86M Sep/2025
Tectonic Therapeutic USD 876K 115K Dec/2024
Tilray USD 640.95M 35.17M Jun/2022
Viatris USD 14.41B 25.6M Dec/2025
Xeris Pharmaceuticals USD 257.65M 431K Sep/2025